Make cataract patients happier and stop worrying about compliance with "dropless" cataract surgery from Imprimis Pharmaceuticals. Many elderly patients struggle with placing eyedrops after surgery and comply poorly as a result. Now they don't have to; surgeons can inject sterile compounded formulations from Imprimis after implanting the IOL, obviating the need for drops. Two formulations are available: One containing triamcinolone and moxifloxacin, the other containing both agents plus vancomycin.
For more information, call 858-704-4028, visit www.godropless.com or click on "Learn More" below.
Your product information request has been received and we will forward information to the contact information you provided shortly.